Tracon Pharmaceuticals Inc Expected To Post A Loss Of 42 Cents A Share: Earnings Preview

TRACON Pharmaceuticals

29/04/2022 12:39

* TRACON Pharmaceuticals Inc  TCON.OQ   TCON.O  is expected
to show no change in quarterly revenue when it reports 
results on May 3 (estimated). 
    * ​Refinitiv's mean analyst estimate for TRACON
Pharmaceuticals
Inc is for a loss of 42 cents per share. For the same quarter
last year, the company reported a loss of 33 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months. ​
    * Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $11​, above​ its last closing price
of $2.07. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.36       -0.35      -0.40     Missed  -13.4
 Sep. 30 2021  -0.32       -0.32      -0.38     Missed  -17.2
 Jun. 30 2021  -0.32       -0.31      -0.58     Missed  -86.2​
 Mar. 31 2021  -0.30       -0.30      -0.33     Missed  -8.2
 ​​Dec.        -0.44       -0.41      -0.31     Beat    23.6
 31 2020                                                
 Sep. 30 2020  -0.64       -0.65      -0.38     Beat    41.5​
 Jun. 30 2020  -0.73       -0.73      -0.70     Beat    3.7
 Mar. 31 2020  -1.12       -1.13      -0.78     Beat    31.1
 This summary was machine generated April 29 at 11:39 GMT.  All
figures in US dollars  unless otherwise stated